Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements
ObjectivesDespite the publication of hundreds of trials on gout and hyperuricemia, management of these conditions remains suboptimal. We aimed to assess the quality and consistency of guidance documents for gout and hyperuricemia.DesignSystematic review and quality assessment using the appraisal of...
Saved in:
| Published in | BMJ open Vol. 9; no. 8; p. e026677 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
British Medical Journal Publishing Group
01.08.2019
BMJ Publishing Group LTD BMJ Publishing Group |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2044-6055 2044-6055 |
| DOI | 10.1136/bmjopen-2018-026677 |
Cover
| Abstract | ObjectivesDespite the publication of hundreds of trials on gout and hyperuricemia, management of these conditions remains suboptimal. We aimed to assess the quality and consistency of guidance documents for gout and hyperuricemia.DesignSystematic review and quality assessment using the appraisal of guidelines for research and evaluation (AGREE) II methodology.Data sourcesPubMed and EMBASE (27 October 2016), two Chinese academic databases, eight guideline databases, and Google and Google scholar (July 2017).Eligibility criteriaWe included the latest version of international and national/regional clinical practice guidelines and consensus statements for diagnosis and/or treatment of hyperuricemia and gout, published in English or Chinese.Data extraction and synthesisTwo reviewers independently screened searched items and extracted data. Four reviewers independently scored documents using AGREE II. Recommendations from all documents were tabulated and visualised in a coloured grid.ResultsTwenty-four guidance documents (16 clinical practice guidelines and 8 consensus statements) published between 2003 and 2017 were included. Included documents performed well in the domains of scope and purpose (median 85.4%, range 66.7%–100.0%) and clarity of presentation (median 79.2%, range 48.6%–98.6%), but unsatisfactory in applicability (median 10.9%, range 0.0%–66.7%) and editorial independence (median 28.1%, range 0.0%–83.3%). The 2017 British Society of Rheumatology guideline received the highest scores. Recommendations were concordant on the target serum uric acid level for long-term control, on some indications for urate-lowering therapy (ULT), and on the first-line drugs for ULT and for acute attack. Substantially inconsistent recommendations were provided for many items, especially for the timing of initiation of ULT and for treatment for asymptomatic hyperuricemia.ConclusionsMethodological quality needs improvement in guidance documents on gout and hyperuricemia. Evidence for certain clinical questions is lacking, despite numerous trials in this field. Promoting standard guidance development methods and synthesising high-quality clinical evidence are potential approaches to reduce recommendation inconsistencies.PROSPERO registration numberCRD42016046104. |
|---|---|
| AbstractList | Objectives Despite the publication of hundreds of trials on gout and hyperuricemia, management of these conditions remains suboptimal. We aimed to assess the quality and consistency of guidance documents for gout and hyperuricemia.Design Systematic review and quality assessment using the appraisal of guidelines for research and evaluation (AGREE) II methodology.Data sources PubMed and EMBASE (27 October 2016), two Chinese academic databases, eight guideline databases, and Google and Google scholar (July 2017).Eligibility criteria We included the latest version of international and national/regional clinical practice guidelines and consensus statements for diagnosis and/or treatment of hyperuricemia and gout, published in English or Chinese.Data extraction and synthesis Two reviewers independently screened searched items and extracted data. Four reviewers independently scored documents using AGREE II. Recommendations from all documents were tabulated and visualised in a coloured grid.Results Twenty-four guidance documents (16 clinical practice guidelines and 8 consensus statements) published between 2003 and 2017 were included. Included documents performed well in the domains of scope and purpose (median 85.4%, range 66.7%–100.0%) and clarity of presentation (median 79.2%, range 48.6%–98.6%), but unsatisfactory in applicability (median 10.9%, range 0.0%–66.7%) and editorial independence (median 28.1%, range 0.0%–83.3%). The 2017 British Society of Rheumatology guideline received the highest scores. Recommendations were concordant on the target serum uric acid level for long-term control, on some indications for urate-lowering therapy (ULT), and on the first-line drugs for ULT and for acute attack. Substantially inconsistent recommendations were provided for many items, especially for the timing of initiation of ULT and for treatment for asymptomatic hyperuricemia.Conclusions Methodological quality needs improvement in guidance documents on gout and hyperuricemia. Evidence for certain clinical questions is lacking, despite numerous trials in this field. Promoting standard guidance development methods and synthesising high-quality clinical evidence are potential approaches to reduce recommendation inconsistencies.PROSPERO registration number CRD42016046104. Despite the publication of hundreds of trials on gout and hyperuricemia, management of these conditions remains suboptimal. We aimed to assess the quality and consistency of guidance documents for gout and hyperuricemia.OBJECTIVESDespite the publication of hundreds of trials on gout and hyperuricemia, management of these conditions remains suboptimal. We aimed to assess the quality and consistency of guidance documents for gout and hyperuricemia.Systematic review and quality assessment using the appraisal of guidelines for research and evaluation (AGREE) II methodology.DESIGNSystematic review and quality assessment using the appraisal of guidelines for research and evaluation (AGREE) II methodology.PubMed and EMBASE (27 October 2016), two Chinese academic databases, eight guideline databases, and Google and Google scholar (July 2017).DATA SOURCESPubMed and EMBASE (27 October 2016), two Chinese academic databases, eight guideline databases, and Google and Google scholar (July 2017).We included the latest version of international and national/regional clinical practice guidelines and consensus statements for diagnosis and/or treatment of hyperuricemia and gout, published in English or Chinese.ELIGIBILITY CRITERIAWe included the latest version of international and national/regional clinical practice guidelines and consensus statements for diagnosis and/or treatment of hyperuricemia and gout, published in English or Chinese.Two reviewers independently screened searched items and extracted data. Four reviewers independently scored documents using AGREE II. Recommendations from all documents were tabulated and visualised in a coloured grid.DATA EXTRACTION AND SYNTHESISTwo reviewers independently screened searched items and extracted data. Four reviewers independently scored documents using AGREE II. Recommendations from all documents were tabulated and visualised in a coloured grid.Twenty-four guidance documents (16 clinical practice guidelines and 8 consensus statements) published between 2003 and 2017 were included. Included documents performed well in the domains of scope and purpose (median 85.4%, range 66.7%-100.0%) and clarity of presentation (median 79.2%, range 48.6%-98.6%), but unsatisfactory in applicability (median 10.9%, range 0.0%-66.7%) and editorial independence (median 28.1%, range 0.0%-83.3%). The 2017 British Society of Rheumatology guideline received the highest scores. Recommendations were concordant on the target serum uric acid level for long-term control, on some indications for urate-lowering therapy (ULT), and on the first-line drugs for ULT and for acute attack. Substantially inconsistent recommendations were provided for many items, especially for the timing of initiation of ULT and for treatment for asymptomatic hyperuricemia.RESULTSTwenty-four guidance documents (16 clinical practice guidelines and 8 consensus statements) published between 2003 and 2017 were included. Included documents performed well in the domains of scope and purpose (median 85.4%, range 66.7%-100.0%) and clarity of presentation (median 79.2%, range 48.6%-98.6%), but unsatisfactory in applicability (median 10.9%, range 0.0%-66.7%) and editorial independence (median 28.1%, range 0.0%-83.3%). The 2017 British Society of Rheumatology guideline received the highest scores. Recommendations were concordant on the target serum uric acid level for long-term control, on some indications for urate-lowering therapy (ULT), and on the first-line drugs for ULT and for acute attack. Substantially inconsistent recommendations were provided for many items, especially for the timing of initiation of ULT and for treatment for asymptomatic hyperuricemia.Methodological quality needs improvement in guidance documents on gout and hyperuricemia. Evidence for certain clinical questions is lacking, despite numerous trials in this field. Promoting standard guidance development methods and synthesising high-quality clinical evidence are potential approaches to reduce recommendation inconsistencies.CONCLUSIONSMethodological quality needs improvement in guidance documents on gout and hyperuricemia. Evidence for certain clinical questions is lacking, despite numerous trials in this field. Promoting standard guidance development methods and synthesising high-quality clinical evidence are potential approaches to reduce recommendation inconsistencies.CRD42016046104.PROSPERO REGISTRATION NUMBERCRD42016046104. ObjectivesDespite the publication of hundreds of trials on gout and hyperuricemia, management of these conditions remains suboptimal. We aimed to assess the quality and consistency of guidance documents for gout and hyperuricemia.DesignSystematic review and quality assessment using the appraisal of guidelines for research and evaluation (AGREE) II methodology.Data sourcesPubMed and EMBASE (27 October 2016), two Chinese academic databases, eight guideline databases, and Google and Google scholar (July 2017).Eligibility criteriaWe included the latest version of international and national/regional clinical practice guidelines and consensus statements for diagnosis and/or treatment of hyperuricemia and gout, published in English or Chinese.Data extraction and synthesisTwo reviewers independently screened searched items and extracted data. Four reviewers independently scored documents using AGREE II. Recommendations from all documents were tabulated and visualised in a coloured grid.ResultsTwenty-four guidance documents (16 clinical practice guidelines and 8 consensus statements) published between 2003 and 2017 were included. Included documents performed well in the domains of scope and purpose (median 85.4%, range 66.7%–100.0%) and clarity of presentation (median 79.2%, range 48.6%–98.6%), but unsatisfactory in applicability (median 10.9%, range 0.0%–66.7%) and editorial independence (median 28.1%, range 0.0%–83.3%). The 2017 British Society of Rheumatology guideline received the highest scores. Recommendations were concordant on the target serum uric acid level for long-term control, on some indications for urate-lowering therapy (ULT), and on the first-line drugs for ULT and for acute attack. Substantially inconsistent recommendations were provided for many items, especially for the timing of initiation of ULT and for treatment for asymptomatic hyperuricemia.ConclusionsMethodological quality needs improvement in guidance documents on gout and hyperuricemia. Evidence for certain clinical questions is lacking, despite numerous trials in this field. Promoting standard guidance development methods and synthesising high-quality clinical evidence are potential approaches to reduce recommendation inconsistencies.PROSPERO registration numberCRD42016046104. Despite the publication of hundreds of trials on gout and hyperuricemia, management of these conditions remains suboptimal. We aimed to assess the quality and consistency of guidance documents for gout and hyperuricemia. Systematic review and quality assessment using the appraisal of guidelines for research and evaluation (AGREE) II methodology. PubMed and EMBASE (27 October 2016), two Chinese academic databases, eight guideline databases, and Google and Google scholar (July 2017). We included the latest version of international and national/regional clinical practice guidelines and consensus statements for diagnosis and/or treatment of hyperuricemia and gout, published in English or Chinese. Two reviewers independently screened searched items and extracted data. Four reviewers independently scored documents using AGREE II. Recommendations from all documents were tabulated and visualised in a coloured grid. Twenty-four guidance documents (16 clinical practice guidelines and 8 consensus statements) published between 2003 and 2017 were included. Included documents performed well in the domains of scope and purpose (median 85.4%, range 66.7%-100.0%) and clarity of presentation (median 79.2%, range 48.6%-98.6%), but unsatisfactory in applicability (median 10.9%, range 0.0%-66.7%) and editorial independence (median 28.1%, range 0.0%-83.3%). The 2017 British Society of Rheumatology guideline received the highest scores. Recommendations were concordant on the target serum uric acid level for long-term control, on some indications for urate-lowering therapy (ULT), and on the first-line drugs for ULT and for acute attack. Substantially inconsistent recommendations were provided for many items, especially for the timing of initiation of ULT and for treatment for asymptomatic hyperuricemia. Methodological quality needs improvement in guidance documents on gout and hyperuricemia. Evidence for certain clinical questions is lacking, despite numerous trials in this field. Promoting standard guidance development methods and synthesising high-quality clinical evidence are potential approaches to reduce recommendation inconsistencies. CRD42016046104. |
| Author | Hemingway, Harry Li, Ling Tian, Haoming Chen, Yaolong Li, Sheyu Li, Xiaodan Shah, Anoop Li, Qianrui Wang, Jing An, Zhenmei Sun, Xin Liu, Hongdie Kwong, Joey Sum-Wing Chen, Hao Chung, Sheng-Chia |
| AuthorAffiliation | 5 Jockey Club School of Public Health and Primary Care , Prince of Wales Hospital, The Chinese University of Hong Kong , Hong Kong , China 9 Health Data Research UK London , University College London , London , UK 12 Division of Population Health and Genomics , Ninewells Hospital and School of Medicine, University of Dundee , Dundee , United Kingdom 11 Evidence-Based Medicine Center , School of Basic Medical Sciences, Lanzhou University , Lanzhou , China 8 Farr Institute of Health Informatics Research , University College London , London , UK 6 The Second Clinical College , Nanjing University of Chinese Medicine , Nanjing , China 2 Institute of Health Informatics , University College London , London , UK 3 Department of Gastroenterology , West China Hospital, Sichuan University , Chengdu , China 10 The National Institute for Health Research University College London Hospitals Biomedical Research Centre , University College London , London , UK 1 Department of Endocrinology and Metabolism , West |
| AuthorAffiliation_xml | – name: 3 Department of Gastroenterology , West China Hospital, Sichuan University , Chengdu , China – name: 1 Department of Endocrinology and Metabolism , West China Hospital, Sichuan University , Chengdu , China – name: 9 Health Data Research UK London , University College London , London , UK – name: 7 Chinese Evidence-Based Medicine Center , West China Hospital, Sichuan University , Chengdu , China – name: 11 Evidence-Based Medicine Center , School of Basic Medical Sciences, Lanzhou University , Lanzhou , China – name: 6 The Second Clinical College , Nanjing University of Chinese Medicine , Nanjing , China – name: 12 Division of Population Health and Genomics , Ninewells Hospital and School of Medicine, University of Dundee , Dundee , United Kingdom – name: 5 Jockey Club School of Public Health and Primary Care , Prince of Wales Hospital, The Chinese University of Hong Kong , Hong Kong , China – name: 8 Farr Institute of Health Informatics Research , University College London , London , UK – name: 2 Institute of Health Informatics , University College London , London , UK – name: 4 Department of Oto-Rhino-Laryngology , West China Hospital, Sichuan University , Chengdu , China – name: 10 The National Institute for Health Research University College London Hospitals Biomedical Research Centre , University College London , London , UK |
| Author_xml | – sequence: 1 givenname: Qianrui surname: Li fullname: Li, Qianrui organization: Institute of Health Informatics, University College London, London, UK – sequence: 2 givenname: Xiaodan surname: Li fullname: Li, Xiaodan organization: Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China – sequence: 3 givenname: Jing surname: Wang fullname: Wang, Jing organization: Department of Oto-Rhino-Laryngology, West China Hospital, Sichuan University, Chengdu, China – sequence: 4 givenname: Hongdie surname: Liu fullname: Liu, Hongdie organization: Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China – sequence: 5 givenname: Joey Sum-Wing surname: Kwong fullname: Kwong, Joey Sum-Wing organization: Jockey Club School of Public Health and Primary Care, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China – sequence: 6 givenname: Hao surname: Chen fullname: Chen, Hao organization: The Second Clinical College, Nanjing University of Chinese Medicine, Nanjing, China – sequence: 7 givenname: Ling surname: Li fullname: Li, Ling organization: Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, China – sequence: 8 givenname: Sheng-Chia surname: Chung fullname: Chung, Sheng-Chia organization: Institute of Health Informatics, University College London, London, UK – sequence: 9 givenname: Anoop surname: Shah fullname: Shah, Anoop organization: The National Institute for Health Research University College London Hospitals Biomedical Research Centre, University College London, London, UK – sequence: 10 givenname: Yaolong surname: Chen fullname: Chen, Yaolong organization: Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China – sequence: 11 givenname: Zhenmei surname: An fullname: An, Zhenmei organization: Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China – sequence: 12 givenname: Xin surname: Sun fullname: Sun, Xin organization: Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, China – sequence: 13 givenname: Harry orcidid: 0000-0003-2279-0624 surname: Hemingway fullname: Hemingway, Harry organization: The National Institute for Health Research University College London Hospitals Biomedical Research Centre, University College London, London, UK – sequence: 14 givenname: Haoming surname: Tian fullname: Tian, Haoming organization: Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China – sequence: 15 givenname: Sheyu orcidid: 0000-0003-0060-0287 surname: Li fullname: Li, Sheyu email: lisheyu@gmail.com organization: Division of Population Health and Genomics, Ninewells Hospital and School of Medicine, University of Dundee, Dundee, United Kingdom |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31446403$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNUk1v1DAQjVARLaW_AAlZ4sIlrb-dcECqylelSlzgbDnOeOtVYi92UtQbPx1vsyxtD4AvtmbeezPjec-rgxADVNVLgk8JYfKsG9dxA6GmmDQ1plIq9aQ6opjzWmIhDu69D6uTnNe4HC5aIeiz6pARziXH7Kj6-d6bVYjZZ2RCj6YEZhohTMjFhK5vN5Dm5C2M3tzlV3Ge3iKD8m2eYDSTtyjBjYcfKDpkBx-8NQPaJGNLCtBq9j2UKCzqNoYMIc8Z5ckUfqmTX1RPnRkynOzu4-rbxw9fLz7XV18-XV6cX9Wd5HyqewXMUqeokbSTzggCVDWMdW3rWAtWCWFxTxrHJMWKCwvW9M4prKwgwnTsuLpcdPto1nqT_GjSrY7G67tATCttUml6AN1L5XonW8x6wUnrGiw6TkgDxHBhGC1a7xatzdyN0NsyRzLDA9GHmeCv9SreaKnKVqQsAm92Ail-nyFPevTZwjCYAHHOmtJSUwiieIG-fgRdxzmF8lVbVKOooIwV1Kv7He1b-b3oAmALwKaYcwK3hxCst47SO0fpraP04qjCah-xrC-b83E7lh_-wT1duCX5n8XO_hD2Q_6N8QuMvvM_ |
| CitedBy_id | crossref_primary_10_1016_j_ejim_2020_05_016 crossref_primary_10_1016_j_berh_2021_101723 crossref_primary_10_1093_ndt_gfad201 crossref_primary_10_14412_1996_7012_2021_4_107_112 crossref_primary_10_21518_2079_701X_2019_18_76_84 crossref_primary_10_1056_NEJMcp2203385 crossref_primary_10_3390_ijerph18020387 crossref_primary_10_1038_s41598_020_77184_x crossref_primary_10_23736_S1825_859X_23_00195_0 crossref_primary_10_1186_s13075_021_02706_5 crossref_primary_10_3389_fnut_2025_1492708 crossref_primary_10_3390_jcm10030448 crossref_primary_10_1007_s40200_024_01528_x crossref_primary_10_1016_j_ejim_2020_01_001 crossref_primary_10_2174_0929867331666230809143758 crossref_primary_10_1136_bmjopen_2024_084759 crossref_primary_10_38109_2075_082X_2022_1_5_22 crossref_primary_10_4103_ETMJ_TMJ_111008 crossref_primary_10_7717_peerj_17926 crossref_primary_10_1016_j_radcr_2022_01_005 crossref_primary_10_3390_ph16040522 crossref_primary_10_1002_cmdc_202400598 crossref_primary_10_1007_s00296_020_04712_3 crossref_primary_10_30841_2307_5112_1_2_2022_260499 crossref_primary_10_26442_00403660_2022_12_201999 crossref_primary_10_3390_ph17111507 crossref_primary_10_1186_s41927_024_00449_9 crossref_primary_10_1186_s12889_023_16669_6 crossref_primary_10_1186_s13098_024_01268_1 crossref_primary_10_1111_jcpt_13156 crossref_primary_10_3389_fmed_2021_649505 crossref_primary_10_22141_2307_1257_10_1_2021_227201 crossref_primary_10_2147_IJGM_S401889 crossref_primary_10_1038_s41440_023_01273_3 crossref_primary_10_1038_s41392_024_01916_y crossref_primary_10_1371_journal_pone_0287352 crossref_primary_10_1016_j_hjc_2022_03_009 crossref_primary_10_1111_dom_15466 crossref_primary_10_1186_s12877_024_05366_7 crossref_primary_10_1186_s13063_022_06479_3 crossref_primary_10_1016_j_mgene_2021_100942 crossref_primary_10_2459_JCM_0000000000001666 crossref_primary_10_1016_j_pmedr_2024_102673 crossref_primary_10_1177_09733698241231347 crossref_primary_10_3390_foods12050982 crossref_primary_10_1007_s11906_020_01116_3 crossref_primary_10_1038_s41598_023_31762_x crossref_primary_10_1002_mnfr_202401017 crossref_primary_10_1093_ckj_sfz136 crossref_primary_10_15829_1728_8800_2024_3737 crossref_primary_10_1007_s00330_023_09786_8 crossref_primary_10_55783_AMF_201007 crossref_primary_10_1186_s12944_023_01846_8 crossref_primary_10_1016_j_heliyon_2022_e11919 crossref_primary_10_3389_fendo_2020_622589 crossref_primary_10_2147_IJGM_S458089 crossref_primary_10_1186_s13643_021_01645_1 crossref_primary_10_1177_15598276231210810 crossref_primary_10_1016_j_ijpx_2023_100199 crossref_primary_10_1186_s12902_022_01192_3 crossref_primary_10_3390_ijms241914462 crossref_primary_10_1007_s11356_022_25051_9 crossref_primary_10_21603_2074_9414_2024_4_2536 crossref_primary_10_1038_s41467_023_38602_6 crossref_primary_10_1016_j_jep_2025_119409 crossref_primary_10_3390_molecules28166048 crossref_primary_10_1016_j_ejim_2022_02_017 crossref_primary_10_3389_fmed_2021_698437 crossref_primary_10_1186_s41927_023_00335_w crossref_primary_10_3389_fcvm_2022_1062894 crossref_primary_10_4103_ijrh_ijrh_6_20 crossref_primary_10_1016_j_ejr_2020_08_008 crossref_primary_10_1016_j_bone_2020_115519 crossref_primary_10_1002_ejhf_2433 crossref_primary_10_2478_rojost_2020_0011 crossref_primary_10_3390_jcm13164884 crossref_primary_10_3390_jcm10194505 crossref_primary_10_1007_s00228_020_02849_5 crossref_primary_10_1016_j_pmedr_2024_102843 crossref_primary_10_1186_s13099_024_00615_x crossref_primary_10_3390_nu16172968 crossref_primary_10_47360_1995_4484_2022_205_213 crossref_primary_10_2147_TCRM_S424598 crossref_primary_10_1186_s13018_022_03046_z crossref_primary_10_1080_02648725_2023_2204715 crossref_primary_10_3390_gucdd1010006 crossref_primary_10_1016_j_freeradbiomed_2021_11_004 crossref_primary_10_1038_s41598_024_83126_8 crossref_primary_10_1007_s10389_022_01787_z crossref_primary_10_1007_s10067_020_05095_3 crossref_primary_10_31718_2077_1096_23_3_217 crossref_primary_10_2147_IJGM_S341622 crossref_primary_10_1007_s11596_023_2778_6 crossref_primary_10_1016_j_numecd_2023_06_001 crossref_primary_10_3389_fmicb_2023_1111652 crossref_primary_10_1016_j_atherosclerosis_2020_08_006 crossref_primary_10_3389_fendo_2022_749368 crossref_primary_10_1111_jmwh_13286 crossref_primary_10_1186_s13223_021_00637_z |
| Cites_doi | 10.3949/ccjm.69.8.594 10.1002/art.22767 10.1186/s12871-015-0150-5 10.1136/annrheumdis-2013-204647 10.1371/journal.pone.0058625 10.7326/M16-0570 10.1002/art.23176 10.3810/pgm.2011.11.2511 10.1007/s12020-018-1535-2 10.3238/arztebl.2009.0549 10.4103/0366-6999.216416 10.1038/nrrheum.2012.216 10.1111/1756-185X.12557 10.1136/ard.2006.055251 10.1503/cmaj.091714 10.1136/ard.2006.055269 10.1097/BOR.0000000000000034 10.1002/art.24207 10.7326/0003-4819-160-1-201401070-00732 10.1136/qshc.2010.042077 10.1016/j.semarthrit.2016.10.009 10.1136/bmjopen-2016-014928 10.1177/1062860615574863 10.7326/M16-0569 10.1111/1756-185X.13266 10.1159/000077906 10.1038/nrrheum.2017.126 10.1371/journal.pone.0095369 10.1373/clinchem.2005.056952 10.1016/j.jclinepi.2014.07.005 10.1038/nrrheum.2015.91 10.1002/acr.22591 10.1093/rheumatology/kex253 10.1136/annrheumdis-2013-204463 10.1136/bmj.j5158 10.1097/BOR.0000000000000154 10.1136/annrheumdis-2013-203325 10.1093/rheumatology/kex150 10.4081/reumatismo.2013.4 10.1155/2015/762820 10.1136/annrheumdis-2015-208237 10.1136/annrheumdis-2016-209707 10.1136/bmj.j2376 10.7326/0003-4819-156-5-201203060-00009 10.1002/acr.23185 10.1186/1741-7015-11-191 10.1097/RHU.0000000000000921 10.1002/art.23007 10.1002/acr.21773 10.1080/15257770.2011.596496 10.7326/M16-2426 10.3760/cma.j.issn.0578-1426.2017.03.021 10.1016/j.jhep.2017.06.028 10.1503/cmaj.090449 10.1186/s12916-014-0231-1 10.1002/acr.21772 10.1136/bmj.318.7183.593 10.1136/annrheumdis-2016-209467 10.1155/2015/690690 |
| ContentType | Journal Article |
| Copyright | Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2019 |
| Copyright_xml | – notice: Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. – notice: 2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2019 |
| DBID | 9YT ACMMV AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 88G 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR BTHHO CCPQU DWQXO FYUFA GHDGH GNUQQ K9- K9. KB0 M0R M0S M1P M2M NAPCQ PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PSYQQ Q9U 7X8 5PM DOA |
| DOI | 10.1136/bmjopen-2018-026677 |
| DatabaseName | BMJ Open Access Journals BMJ Journals:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central BMJ Journals ProQuest One Community College ProQuest Central Korea Health Research Premium Collection (UHCL Subscription) Health Research Premium Collection (Alumni) ProQuest Central Student Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Consumer Health Database ProQuest Health & Medical Collection Medical Database Psychology Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Family Health (Alumni Edition) ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition BMJ Journals ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ (Directory of Open Access Journals) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: ACMMV name: BMJ Journals:Open Access url: https://journals.bmj.com/ sourceTypes: Publisher – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2044-6055 |
| ExternalDocumentID | oai_doaj_org_article_d67fdf6903d5419f805b4118e1a45a32 PMC6720466 31446403 10_1136_bmjopen_2018_026677 bmjopen |
| Genre | Research Support, Non-U.S. Gov't Systematic Review Journal Article |
| GeographicLocations | United States--US |
| GeographicLocations_xml | – name: United States--US |
| GrantInformation_xml | – fundername: Talents Cultivation Fund of West China Hospital – fundername: Scientific Research Project of Health and Family Planning Commission of Sichuan Province grantid: 130029; 150149; 17PJ063; 17PJ445 – fundername: The BigData@Heart Consortium – fundername: Health Data Research UK – fundername: National Institute for Health Research University College London Hospitals Biomedical Research Centre – fundername: National Natural Science Foundation of China grantid: 21534008; 81400811 funderid: http://dx.doi.org/10.13039/501100001809 – fundername: The International Visiting Program for Excellent Young Scholars of Sichuan University – fundername: Cholesterol Fund by China Cardiovascular Foundation and China Heart House – fundername: 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University grantid: ZYGD18022 – fundername: Sichuan Science and Technology Program grantid: 2019YFH0150 – fundername: Chief Scientist Office – fundername: Wellcome Trust – fundername: Medical Research Council – fundername: British Heart Foundation – fundername: ; – fundername: ; grantid: ZYGD18022 – fundername: ; grantid: 130029; 150149; 17PJ063; 17PJ445 – fundername: ; grantid: 21534008; 81400811 – fundername: ; grantid: 2019YFH0150 – fundername: ; grantid: 2015CB942800 |
| GroupedDBID | --- 4.4 53G 5VS 7RV 7X7 7~R 88E 8FI 8FJ 9YT ABUWG ACGFS ACMMV ADBBV AENEX AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BKNYI BPHCQ BTFSW BTHHO CCPQU DIK DWQXO EBS FYUFA GNUQQ GROUPED_DOAJ GX1 H13 HMCUK HYE HZ~ K9- KQ8 M0R M1P M2M M48 M~E NAPCQ O9- OK1 PGMZT PHGZT PIMPY PQQKQ PROAC PSQYO PSYQQ RHI RMJ RPM UKHRP ADRAZ BVXVI EJD AAYXX CITATION PHGZM CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK K9. PJZUB PKEHL PPXIY PQEST PQUKI Q9U 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-b644t-d7e3c2f72a62b6fa51e27833b99f39ec755c0d18f3620745cecadff707c515ab3 |
| IEDL.DBID | 9YT |
| ISSN | 2044-6055 |
| IngestDate | Wed Aug 27 01:32:57 EDT 2025 Thu Aug 21 18:29:59 EDT 2025 Thu Sep 04 16:31:22 EDT 2025 Sat Jul 26 00:42:51 EDT 2025 Thu Apr 03 08:16:36 EDT 2025 Tue Jul 01 02:59:50 EDT 2025 Thu Apr 24 22:57:53 EDT 2025 Fri Apr 25 03:29:48 EDT 2025 Thu Apr 24 22:50:27 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Keywords | clinical practice guideline hyperuricemia systematic review gout |
| Language | English |
| License | This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b644t-d7e3c2f72a62b6fa51e27833b99f39ec755c0d18f3620745cecadff707c515ab3 |
| Notes | Research ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 QL and XL are joint first authors. |
| ORCID | 0000-0003-0060-0287 0000-0003-2279-0624 |
| OpenAccessLink | http://dx.doi.org/10.1136/bmjopen-2018-026677 |
| PMID | 31446403 |
| PQID | 2288725233 |
| PQPubID | 2040975 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_d67fdf6903d5419f805b4118e1a45a32 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6720466 proquest_miscellaneous_2280555174 proquest_journals_2288725233 pubmed_primary_31446403 crossref_primary_10_1136_bmjopen_2018_026677 crossref_citationtrail_10_1136_bmjopen_2018_026677 bmj_primary_10_1136_bmjopen_2018_026677 bmj_journals_10_1136_bmjopen_2018_026677 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2019-08-01 |
| PublicationDateYYYYMMDD | 2019-08-01 |
| PublicationDate_xml | – month: 08 year: 2019 text: 2019-08-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London – name: BMA House, Tavistock Square, London, WC1H 9JR |
| PublicationTitle | BMJ open |
| PublicationTitleAbbrev | BMJ Open |
| PublicationTitleAlternate | BMJ Open |
| PublicationYear | 2019 |
| Publisher | British Medical Journal Publishing Group BMJ Publishing Group LTD BMJ Publishing Group |
| Publisher_xml | – name: British Medical Journal Publishing Group – name: BMJ Publishing Group LTD – name: BMJ Publishing Group |
| References | Holmer, Ogden, Burda (R59) 2013; 8 Khanna, Fitzgerald, Khanna (R14) 2012; 64 Neogi, Jansen, Dalbeth (R42) 2015; 74 Araújo, Cordeiro, Teixeira (R40) 2014; 39 Tausche, Jansen, Schröder (R8) 2009; 106 Pittman, Bross (R10) 1999; 59 Yu, Chen, Chen (R55) 2018; 21 Fang, Yao, Sun (R61) 2018; 60 McLean (R23) 2017; 166 Graf, Whittle, Wechalekar (R43) 2015; 18 (R38) 2016; 30 Wu, Wu, Young (R60) 2016; 31 Brosseau, Rahman, Poitras (R71) 2014; 9 Shekelle, Woolf, Eccles (R53) 1999; 318 Khanna, FitzGerald (R26) 2015; 27 Lopez-Olivo, Kallen, Ortiz (R32) 2008; 59 Tunnicliffe, Singh-Grewal, Kim (R64) 2015; 67 Qaseem, McLean, Starkey (R19) 2017; 166 Singh, Hodges, Toscano (R12) 2007; 57 Li, Vedula, Scherer (R70) 2012; 156 (R41) 2016; 55 Hazlewood, Akhavan, Schieir (R62) 2014; 67 Yamanaka (R48) 2011; 30 Perez-Ruiz, Lioté (R11) 2007; 57 Deng, Luo, Hu (R30) 2016; 16 Zhang, Doherty, Pascual (R18) 2006; 65 Brouwers, Kho, Browman (R28) 2010; 182 Huang, Lai, Wu (R31) 2013; 11 (R22) 2017; 56 Lawrence, Felson, Helmick (R1) 2008; 58 Hui, Carr, Cameron (R21) 2017; 56 Wang, Yu, Chen (R57) 2018 Devroey, Vantomme, Betz (R66) 2004; 102 Manara, Bortoluzzi, Favero (R45) 2013; 65 Zhang, Doherty, Bardin (R58) 2006; 65 (R54) 2017; 130 Alonso-Coello, Irfan, Solà (R65) 2010; 19 Chen, Wang, Shang (R13) 2018; 360 Hamburger, Baraf, Adamson (R17) 2011; 123 Nuki (R56) 2014; 26 Kuo, Grainge, Mallen (R6) 2015; 74 Smith, Hoy, Cross (R5) 2014; 73 Meyers, Cassim, Mody (R51) 2003; 93 Plumpton, Alfirevic, Pirmohamed (R69) 2017; 56 Nuckols, Anderson, Popescu (R29) 2014; 160 Palmowski, Buttgereit, Dejaco (R63) 2017; 69 Li-Yu, Salido, Manahan (R50) Bardin, Richette (R24) 2013; 9 Sivera, Andrés, Carmona (R36) 2014; 73 Gavriilidis, Roberts, Askari (R67) 2017; 67 Dalbeth, Bardin, Doherty (R25) 2017; 13 Kuo, Grainge, Zhang (R3) 2015; 11 Richette, Doherty, Pascual (R16) 2017; 76 Smith (R4) 2015; 67 Dincer, Dincer, Levinson (R9) 2002; 69 Kiltz, Smolen, Bardin (R39) 2016; 76 Watine, Friedberg, Nagy (R72) 2006; 52 Brouwers, Kho, Browman (R35) 2010; 182 Jutkowitz, Dubreuil, Lu (R68) 2017; 46 Khanna, Khanna, Fitzgerald (R15) 2012; 64 Nagler, Vanmassenhove, van der Veer (R33) 2014; 12 (R37) 2013; 29 Liu, Han, Wu (R2) 2015; 2015 Li, Li, Kwong (R27) 2017; 7 Qaseem, Harris, Forciea (R20) 2017; 166 Li, Meng, Timofeeva (R7) 2017; 357 Hu (R47) 2012; 10 Singh, Hodges, Toscano 2007; 57 Li, Li, Kwong 2017; 7 2013; 29 Chen, Wang, Shang 2018; 360 Graf, Whittle, Wechalekar 2015; 18 Hu 2012; 10 Palmowski, Buttgereit, Dejaco 2017; 69 Watine, Friedberg, Nagy 2006; 52 Kuo, Grainge, Zhang 2015; 11 Smith, Hoy, Cross 2014; 73 Deng, Luo, Hu 2016; 16 2016; 30 Yamanaka 2011; 30 Holmer, Ogden, Burda 2013; 8 Khanna, Khanna, Fitzgerald 2012; 64 Lawrence, Felson, Helmick 2008; 58 Smith 2015; 67 Li, Meng, Timofeeva 2017; 357 Meyers, Cassim, Mody 2003; 93 Hamburger, Baraf, Adamson 2011; 123 Pittman, Bross 1999; 59 Manara, Bortoluzzi, Favero 2013; 65 Li-Yu, Salido, Manahan Shekelle, Woolf, Eccles 1999; 318 Qaseem, McLean, Starkey 2017; 166 Wu, Wu, Young 2016; 31 Liu, Han, Wu 2015; 2015 Alonso-Coello, Irfan, Solà 2010; 19 Devroey, Vantomme, Betz 2004; 102 Qaseem, Harris, Forciea 2017; 166 Khanna, FitzGerald 2015; 27 Hui, Carr, Cameron 2017; 56 Brouwers, Kho, Browman 2010; 182 Gavriilidis, Roberts, Askari 2017; 67 Khanna, Fitzgerald, Khanna 2012; 64 Richette, Doherty, Pascual 2017; 76 Nagler, Vanmassenhove, van der Veer 2014; 12 Tunnicliffe, Singh-Grewal, Kim 2015; 67 Araújo, Cordeiro, Teixeira 2014; 39 McLean 2017; 166 Huang, Lai, Wu 2013; 11 Brosseau, Rahman, Poitras 2014; 9 2017; 130 Zhang, Doherty, Pascual 2006; 65 Lopez-Olivo, Kallen, Ortiz 2008; 59 Yu, Chen, Chen 2018; 21 Li, Vedula, Scherer 2012; 156 Sivera, Andrés, Carmona 2014; 73 2016; 55 Plumpton, Alfirevic, Pirmohamed 2017; 56 Hazlewood, Akhavan, Schieir 2014; 67 Perez-Ruiz, Lioté 2007; 57 Nuckols, Anderson, Popescu 2014; 160 Dincer, Dincer, Levinson 2002; 69 Dalbeth, Bardin, Doherty 2017; 13 Tausche, Jansen, Schröder 2009; 106 Kuo, Grainge, Mallen 2015; 74 2017; 56 Bardin, Richette 2013; 9 Fang, Yao, Sun 2018; 60 Neogi, Jansen, Dalbeth 2015; 74 Jutkowitz, Dubreuil, Lu 2017; 46 Kiltz, Smolen, Bardin 2016; 76 Zhang, Doherty, Bardin 2006; 65 Wang, Yu, Chen 2018 Nuki 2014; 26 2024052011302869000_9.8.e026677.50 Huang (2024052011302869000_9.8.e026677.31) 2013; 11 2024052011302869000_9.8.e026677.52 2024052011302869000_9.8.e026677.1 2024052011302869000_9.8.e026677.2 2024052011302869000_9.8.e026677.57 2024052011302869000_9.8.e026677.3 2024052011302869000_9.8.e026677.14 Li (2024052011302869000_9.8.e026677.27) 2017; 7 2024052011302869000_9.8.e026677.58 2024052011302869000_9.8.e026677.15 2024052011302869000_9.8.e026677.5 2024052011302869000_9.8.e026677.16 2024052011302869000_9.8.e026677.6 2024052011302869000_9.8.e026677.53 2024052011302869000_9.8.e026677.11 2024052011302869000_9.8.e026677.9 2024052011302869000_9.8.e026677.12 2024052011302869000_9.8.e026677.56 Brosseau (2024052011302869000_9.8.e026677.71) 2014; 9 2024052011302869000_9.8.e026677.17 2024052011302869000_9.8.e026677.18 (2024052011302869000_9.8.e026677.37) 2013; 29 Pittman (2024052011302869000_9.8.e026677.10) 1999; 59 2024052011302869000_9.8.e026677.46 2024052011302869000_9.8.e026677.48 2024052011302869000_9.8.e026677.49 2024052011302869000_9.8.e026677.42 2024052011302869000_9.8.e026677.43 2024052011302869000_9.8.e026677.44 Nuckols (2024052011302869000_9.8.e026677.29) 2014; 160 Qaseem (2024052011302869000_9.8.e026677.19) 2017; 166 Tunnicliffe (2024052011302869000_9.8.e026677.64) 2015; 67 Deng (2024052011302869000_9.8.e026677.30) 2016; 16 2024052011302869000_9.8.e026677.72 Gavriilidis (2024052011302869000_9.8.e026677.67) 2017; 67 (2024052011302869000_9.8.e026677.22) 2017; 56 Plumpton (2024052011302869000_9.8.e026677.69) 2017; 56 2024052011302869000_9.8.e026677.70 Hui (2024052011302869000_9.8.e026677.21) 2017; 56 2024052011302869000_9.8.e026677.35 Meyers (2024052011302869000_9.8.e026677.51) 2003; 93 2024052011302869000_9.8.e026677.36 2024052011302869000_9.8.e026677.32 2024052011302869000_9.8.e026677.34 (2024052011302869000_9.8.e026677.41) 2016; 55 Palmowski (2024052011302869000_9.8.e026677.63) 2017; 69 McLean (2024052011302869000_9.8.e026677.23) 2017; 166 2024052011302869000_9.8.e026677.39 Li (2024052011302869000_9.8.e026677.7) 2017; 357 Bardin (2024052011302869000_9.8.e026677.24) 2013; 9 2024052011302869000_9.8.e026677.60 Manara (2024052011302869000_9.8.e026677.45) 2013; 65 2024052011302869000_9.8.e026677.62 (2024052011302869000_9.8.e026677.38) 2016; 30 Tausche (2024052011302869000_9.8.e026677.8) 2009; 106 Jutkowitz (2024052011302869000_9.8.e026677.68) 2017; 46 2024052011302869000_9.8.e026677.26 Araújo (2024052011302869000_9.8.e026677.40) 2014; 39 Dalbeth (2024052011302869000_9.8.e026677.25) 2017; 13 2024052011302869000_9.8.e026677.20 2024052011302869000_9.8.e026677.65 2024052011302869000_9.8.e026677.66 Smith (2024052011302869000_9.8.e026677.4) 2015; 67 (2024052011302869000_9.8.e026677.54) 2017; 130 Fang (2024052011302869000_9.8.e026677.61) 2018; 60 2024052011302869000_9.8.e026677.28 Yu (2024052011302869000_9.8.e026677.55) 2018; 21 Hu (2024052011302869000_9.8.e026677.47) 2012; 10 Nagler (2024052011302869000_9.8.e026677.33) 2014; 12 Chen (2024052011302869000_9.8.e026677.13) 2018; 360 Holmer (2024052011302869000_9.8.e026677.59) 2013; 8 |
| References_xml | – volume: 69 start-page: 594 year: 2002 ident: R9 article-title: Asymptomatic hyperuricemia: to treat or not to treat publication-title: Cleve Clin J Med doi: 10.3949/ccjm.69.8.594 – volume: 57 start-page: 822 year: 2007 ident: R12 article-title: Quality of care for gout in the US needs improvement publication-title: Arthritis Rheum doi: 10.1002/art.22767 – volume: 16 year: 2016 ident: R30 article-title: Clinical practice guidelines for the management of neuropathic pain: a systematic review publication-title: BMC Anesthesiol doi: 10.1186/s12871-015-0150-5 – ident: R50 article-title: Philippine clinical practice guidelines for the management of gout publication-title: Int J Rheum Dis – volume: 73 start-page: 1470 year: 2014 ident: R5 article-title: The global burden of gout: estimates from the global burden of disease 2010 study publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2013-204647 – volume: 8 year: 2013 ident: R59 article-title: Quality of clinical practice guidelines for glycemic control in type 2 diabetes mellitus publication-title: PLoS One doi: 10.1371/journal.pone.0058625 – volume: 166 start-page: 58 year: 2017 ident: R20 article-title: Management of acute and recurrent gout: a clinical practice guideline from the American College of physicians publication-title: Ann Intern Med doi: 10.7326/M16-0570 – volume: 39 start-page: 158 year: 2014 ident: R40 article-title: Portuguese recommendations for the diagnosis and management of gout publication-title: Acta Reumatol Port – volume: 58 start-page: 26 year: 2008 ident: R1 article-title: Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II publication-title: Arthritis Rheum doi: 10.1002/art.23176 – volume: 123 start-page: 3 issue: 6 Suppl 1 year: 2011 ident: R17 article-title: 2011 recommendations for the diagnosis and management of gout and hyperuricemia publication-title: Postgrad Med doi: 10.3810/pgm.2011.11.2511 – volume: 60 start-page: 4 year: 2018 ident: R61 article-title: Appraisal of clinical practice guidelines on the management of hypothyroidism in pregnancy using the appraisal of guidelines for research and evaluation II instrument publication-title: Endocrine doi: 10.1007/s12020-018-1535-2 – volume: 106 start-page: 549 year: 2009 ident: R8 article-title: Gout--current diagnosis and treatment publication-title: Dtsch Arztebl Int doi: 10.3238/arztebl.2009.0549 – volume: 130 start-page: 2473 year: 2017 ident: R54 article-title: Chinese multidisciplinary expert consensus on the diagnosis and treatment of hyperuricemia and related diseases publication-title: Chin Med J doi: 10.4103/0366-6999.216416 – volume: 9 start-page: 9 year: 2013 ident: R24 article-title: New ACR guidelines for gout management hold some surprises publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2012.216 – volume: 18 start-page: 341 year: 2015 ident: R43 article-title: Australian and New Zealand recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion in the 3E initiative publication-title: Int J Rheum Dis doi: 10.1111/1756-185X.12557 – volume: 65 start-page: 1301 year: 2006 ident: R18 article-title: EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the standing Committee for international clinical studies including therapeutics (ESCISIT) publication-title: Ann Rheum Dis doi: 10.1136/ard.2006.055251 – volume: 10 start-page: 241 year: 2012 ident: R47 article-title: The diagnosis and treatment advice of cardiovascular disease combined asymptomatic hyperuricemia (second edition) publication-title: Chin J Cardiovas Res – volume: 182 start-page: 1045 year: 2010 ident: R35 article-title: Development of the agree II, part 1: performance, usefulness and areas for improvement publication-title: Can Med Assoc J doi: 10.1503/cmaj.091714 – volume: 65 start-page: 1312 year: 2006 ident: R58 article-title: EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR standing Committee for international clinical studies including therapeutics (ESCISIT) publication-title: Ann Rheum Dis doi: 10.1136/ard.2006.055269 – volume: 26 start-page: 152 year: 2014 ident: R56 article-title: An appraisal of the 2012 American College of rheumatology guidelines for the management of gout publication-title: Curr Opin Rheumatol doi: 10.1097/BOR.0000000000000034 – volume: 59 start-page: 1625 year: 2008 ident: R32 article-title: Quality appraisal of clinical practice guidelines and consensus statements on the use of biologic agents in rheumatoid arthritis: a systematic review publication-title: Arthritis Rheum doi: 10.1002/art.24207 – volume: 160 start-page: 38-47 year: 2014 ident: R29 article-title: Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain publication-title: Ann Intern Med doi: 10.7326/0003-4819-160-1-201401070-00732 – volume: 59 start-page: 1799 year: 1999 ident: R10 article-title: Diagnosis and management of gout publication-title: Am Fam Physician – volume: 19 year: 2010 ident: R65 article-title: The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies publication-title: Qual Saf Health Care doi: 10.1136/qshc.2010.042077 – volume: 46 start-page: 594 year: 2017 ident: R68 article-title: The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States publication-title: Semin Arthritis Rheum doi: 10.1016/j.semarthrit.2016.10.009 – volume: 7 year: 2017 ident: R27 article-title: Diagnosis and treatment for hyperuricaemia and gout: a protocol for a systematic review of clinical practice guidelines and consensus statements publication-title: BMJ Open doi: 10.1136/bmjopen-2016-014928 – volume: 31 start-page: 370 year: 2016 ident: R60 article-title: An appraisal of clinical practice guidelines for diabetic retinopathy publication-title: Am J Med Qual doi: 10.1177/1062860615574863 – volume: 29 start-page: 913 year: 2013 ident: R37 article-title: Chinese consensus on the management of hyperuricemia and gout publication-title: Chin J Endocrinol Metab – volume: 166 start-page: 52 year: 2017 ident: R19 article-title: Diagnosis of acute gout: a clinical practice guideline from the American College of physicians publication-title: Ann Intern Med doi: 10.7326/M16-0569 – volume: 21 start-page: 772 year: 2018 ident: R55 article-title: Management of gout and hyperuricemia: multidisciplinary consensus in Taiwan publication-title: Int J Rheum Dis doi: 10.1111/1756-185X.13266 – volume: 102 start-page: 61 year: 2004 ident: R66 article-title: A review of the treatment guidelines on the management of low levels of high-density lipoprotein cholesterol publication-title: Cardiology doi: 10.1159/000077906 – volume: 13 start-page: 561 year: 2017 ident: R25 article-title: Discordant American College of physicians and international rheumatology guidelines for gout management: consensus statement of the gout, hyperuricemia and Crystal-Associated disease network (G-CAN) publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2017.126 – volume: 9 year: 2014 ident: R71 article-title: A systematic critical appraisal of non-pharmacological management of rheumatoid arthritis with appraisal of guidelines for research and evaluation II publication-title: PLoS One doi: 10.1371/journal.pone.0095369 – volume: 52 start-page: 65 year: 2006 ident: R72 article-title: Conflict between guideline methodologic quality and recommendation validity: a potential problem for practitioners publication-title: Clin Chem doi: 10.1373/clinchem.2005.056952 – volume: 67 start-page: 1274 year: 2014 ident: R62 article-title: Adding a "GRADE" to the quality appraisal of rheumatoid arthritis guidelines identifies limitations beyond AGREE-II publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2014.07.005 – volume: 11 start-page: 649 year: 2015 ident: R3 article-title: Global epidemiology of gout: prevalence, incidence and risk factors publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2015.91 – volume: 67 start-page: 1440 year: 2015 ident: R64 article-title: Diagnosis, monitoring, and treatment of systemic lupus erythematosus: a systematic review of clinical practice guidelines publication-title: Arthritis Care Res doi: 10.1002/acr.22591 – volume: 56 start-page: 1729 year: 2017 ident: R69 article-title: Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for gout publication-title: Rheumatology doi: 10.1093/rheumatology/kex253 – volume: 74 start-page: 661 year: 2015 ident: R6 article-title: Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2013-204463 – volume: 360 year: 2018 ident: R13 article-title: Clinical practice guidelines in China publication-title: BMJ doi: 10.1136/bmj.j5158 – volume: 27 start-page: 139 year: 2015 ident: R26 article-title: Evolution of management of gout: a comparison of recent guidelines publication-title: Curr Opin Rheumatol doi: 10.1097/BOR.0000000000000154 – volume: 73 start-page: 328 year: 2014 ident: R36 article-title: Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3E initiative publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2013-203325 – volume: 55 start-page: 892 year: 2016 ident: R41 article-title: 2016 Chinese guideline on the diagnosis and management of gout publication-title: Chin J Intern Med – volume: 56 start-page: 1056 year: 2017 ident: R21 article-title: The British Society for rheumatology guideline for the management of gout publication-title: Rheumatology doi: 10.1093/rheumatology/kex150 – volume: 65 start-page: 4 year: 2013 ident: R45 article-title: Italian Society of rheumatology recommendations for the management of gout publication-title: Reumatismo doi: 10.4081/reumatismo.2013.4 – volume: 2015 start-page: 1 issue: 15, supplement year: 2015 ident: R2 article-title: Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis publication-title: Biomed Res Int doi: 10.1155/2015/762820 – volume: 74 start-page: 1789 year: 2015 ident: R42 article-title: 2015 gout classification criteria: an American College of Rheumatology/European League against rheumatism collaborative initiative publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2015-208237 – volume: 76 start-page: 29 year: 2017 ident: R16 article-title: 2016 updated EULAR evidence-based recommendations for the management of gout publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2016-209707 – volume: 30 start-page: 1 year: 2016 ident: R38 article-title: Taiwan guideline for the management of gout and hyperuricemia - updated 2016 publication-title: F J Rheumatol – volume: 318 start-page: 593 year: 1999 ident: R53 article-title: Developing guidelines publication-title: BMJ – volume: 357 year: 2017 ident: R7 article-title: Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies publication-title: BMJ doi: 10.1136/bmj.j2376 – volume: 156 start-page: 367 year: 2012 ident: R70 article-title: What comparative effectiveness research is needed? A framework for using guidelines and systematic reviews to identify evidence gaps and research priorities publication-title: Ann Intern Med doi: 10.7326/0003-4819-156-5-201203060-00009 – volume: 69 start-page: 1134 year: 2017 ident: R63 article-title: “Official view” on glucocorticoids in rheumatoid arthritis: a systematic review of international guidelines and consensus statements publication-title: Arthritis Care Res doi: 10.1002/acr.23185 – volume: 11 year: 2013 ident: R31 article-title: Systematic review of clinical practice guidelines in the diagnosis and management of thyroid nodules and cancer publication-title: BMC Med doi: 10.1186/1741-7015-11-191 – volume: 67 start-page: 2690 year: 2015 ident: R4 article-title: March L: Global prevalence of hyperuricemia: a systematic review of population-based epidemiological studies publication-title: Arthritis & Rheumatology – year: 2018 ident: R57 article-title: Assessing the quality of global clinical practice guidelines on gout using agree II instrument publication-title: J Clin Rheumatol doi: 10.1097/RHU.0000000000000921 – volume: 57 start-page: 1324 year: 2007 ident: R11 article-title: Lowering serum uric acid levels: what is the optimal target for improving clinical outcomes in gout? publication-title: Arthritis Rheum doi: 10.1002/art.23007 – volume: 64 start-page: 1447 year: 2012 ident: R15 article-title: 2012 American College of rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis publication-title: Arthritis Care Res doi: 10.1002/acr.21773 – volume: 30 start-page: 1018 year: 2011 ident: R48 article-title: Japanese guideline for the management of hyperuricemia and gout: second edition publication-title: Nucleosides, Nucleotides and Nucleic Acids doi: 10.1080/15257770.2011.596496 – volume: 93 start-page: 961 year: 2003 ident: R51 article-title: Hyperuricaemia and gout: clinical guideline 2003 publication-title: S Afr Med J – volume: 166 start-page: 73 year: 2017 ident: R23 article-title: The long and winding road to clinical guidelines on the diagnosis and management of gout publication-title: Ann Intern Med doi: 10.7326/M16-2426 – volume: 56 start-page: 235 year: 2017 ident: R22 article-title: [Chinese multi-disciplinary consensus on the diagnosis and treatment of hyperuricemia and its related diseases] publication-title: Zhonghua Nei Ke Za Zhi doi: 10.3760/cma.j.issn.0578-1426.2017.03.021 – volume: 67 start-page: 991 year: 2017 ident: R67 article-title: Evaluation of the current guidelines for resection of hepatocellular carcinoma using the appraisal of guidelines for research and evaluation II instrument publication-title: J Hepatol doi: 10.1016/j.jhep.2017.06.028 – volume: 182 start-page: E839 year: 2010 ident: R28 article-title: Agree II: advancing Guideline development, reporting and evaluation in health care publication-title: CMAJ doi: 10.1503/cmaj.090449 – volume: 76 year: 2016 ident: R39 article-title: (T2T) recommendations for gout publication-title: Ann Rheum Dis – volume: 12 year: 2014 ident: R33 article-title: Diagnosis and treatment of hyponatremia: a systematic review of clinical practice guidelines and consensus statements publication-title: BMC Med doi: 10.1186/s12916-014-0231-1 – volume: 64 start-page: 1431 year: 2012 ident: R14 article-title: 2012 American College of rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia publication-title: Arthritis Care Res doi: 10.1002/acr.21772 – volume: 30 start-page: 1 year: 2016 article-title: Taiwan guideline for the management of gout and hyperuricemia - updated 2016 publication-title: F J Rheumatol – volume: 67 start-page: 1440 year: 2015 article-title: Diagnosis, monitoring, and treatment of systemic lupus erythematosus: a systematic review of clinical practice guidelines publication-title: Arthritis Care Res doi: 10.1002/acr.22591 – volume: 166 start-page: 58 year: 2017 article-title: Management of acute and recurrent gout: a clinical practice guideline from the American College of physicians publication-title: Ann Intern Med doi: 10.7326/M16-0570 – volume: 21 start-page: 772 year: 2018 article-title: Management of gout and hyperuricemia: multidisciplinary consensus in Taiwan publication-title: Int J Rheum Dis doi: 10.1111/1756-185X.13266 – volume: 65 start-page: 4 year: 2013 article-title: Italian Society of rheumatology recommendations for the management of gout publication-title: Reumatismo doi: 10.4081/reumatismo.2013.4 – volume: 26 start-page: 152 year: 2014 article-title: An appraisal of the 2012 American College of rheumatology guidelines for the management of gout publication-title: Curr Opin Rheumatol doi: 10.1097/BOR.0000000000000034 – volume: 123 start-page: 3 issue: 6 Suppl 1 year: 2011 article-title: 2011 recommendations for the diagnosis and management of gout and hyperuricemia publication-title: Postgrad Med doi: 10.3810/pgm.2011.11.2511 – volume: 67 start-page: 1274 year: 2014 article-title: Adding a "GRADE" to the quality appraisal of rheumatoid arthritis guidelines identifies limitations beyond AGREE-II publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2014.07.005 – volume: 160 start-page: 38-47 year: 2014 article-title: Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain publication-title: Ann Intern Med doi: 10.7326/0003-4819-160-1-201401070-00732 – volume: 18 start-page: 341 year: 2015 article-title: Australian and New Zealand recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion in the 3E initiative publication-title: Int J Rheum Dis doi: 10.1111/1756-185X.12557 – volume: 8 year: 2013 article-title: Quality of clinical practice guidelines for glycemic control in type 2 diabetes mellitus publication-title: PLoS One doi: 10.1371/journal.pone.0058625 – volume: 57 start-page: 822 year: 2007 article-title: Quality of care for gout in the US needs improvement publication-title: Arthritis Rheum doi: 10.1002/art.22767 – volume: 67 start-page: 2690 year: 2015 article-title: March L: Global prevalence of hyperuricemia: a systematic review of population-based epidemiological studies publication-title: Arthritis & Rheumatology – volume: 64 start-page: 1431 year: 2012 article-title: 2012 American College of rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia publication-title: Arthritis Care Res doi: 10.1002/acr.21772 – volume: 76 year: 2016 article-title: (T2T) recommendations for gout publication-title: Ann Rheum Dis – volume: 59 start-page: 1625 year: 2008 article-title: Quality appraisal of clinical practice guidelines and consensus statements on the use of biologic agents in rheumatoid arthritis: a systematic review publication-title: Arthritis Rheum doi: 10.1002/art.24207 – volume: 360 year: 2018 article-title: Clinical practice guidelines in China publication-title: BMJ doi: 10.1136/bmj.j5158 – volume: 12 year: 2014 article-title: Diagnosis and treatment of hyponatremia: a systematic review of clinical practice guidelines and consensus statements publication-title: BMC Med doi: 10.1186/s12916-014-0231-1 – volume: 29 start-page: 913 year: 2013 article-title: Chinese consensus on the management of hyperuricemia and gout publication-title: Chin J Endocrinol Metab – article-title: Philippine clinical practice guidelines for the management of gout publication-title: Int J Rheum Dis – volume: 58 start-page: 26 year: 2008 article-title: Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II publication-title: Arthritis Rheum doi: 10.1002/art.23176 – volume: 46 start-page: 594 year: 2017 article-title: The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States publication-title: Semin Arthritis Rheum doi: 10.1016/j.semarthrit.2016.10.009 – volume: 74 start-page: 661 year: 2015 article-title: Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2013-204463 – volume: 93 start-page: 961 year: 2003 article-title: Hyperuricaemia and gout: clinical guideline 2003 publication-title: S Afr Med J – volume: 65 start-page: 1301 year: 2006 article-title: EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the standing Committee for international clinical studies including therapeutics (ESCISIT) publication-title: Ann Rheum Dis doi: 10.1136/ard.2006.055251 – volume: 60 start-page: 4 year: 2018 article-title: Appraisal of clinical practice guidelines on the management of hypothyroidism in pregnancy using the appraisal of guidelines for research and evaluation II instrument publication-title: Endocrine doi: 10.1007/s12020-018-1535-2 – volume: 76 start-page: 29 year: 2017 article-title: 2016 updated EULAR evidence-based recommendations for the management of gout publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2016-209707 – volume: 106 start-page: 549 year: 2009 article-title: Gout--current diagnosis and treatment publication-title: Dtsch Arztebl Int doi: 10.3238/arztebl.2009.0549 – volume: 57 start-page: 1324 year: 2007 article-title: Lowering serum uric acid levels: what is the optimal target for improving clinical outcomes in gout? publication-title: Arthritis Rheum doi: 10.1002/art.23007 – volume: 16 year: 2016 article-title: Clinical practice guidelines for the management of neuropathic pain: a systematic review publication-title: BMC Anesthesiol doi: 10.1186/s12871-015-0150-5 – volume: 19 year: 2010 article-title: The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies publication-title: Qual Saf Health Care doi: 10.1136/qshc.2010.042077 – volume: 56 start-page: 1056 year: 2017 article-title: The British Society for rheumatology guideline for the management of gout publication-title: Rheumatology doi: 10.1093/rheumatology/kex150 – volume: 182 start-page: E839 year: 2010 article-title: Agree II: advancing Guideline development, reporting and evaluation in health care publication-title: CMAJ doi: 10.1503/cmaj.090449 – volume: 59 start-page: 1799 year: 1999 article-title: Diagnosis and management of gout publication-title: Am Fam Physician – volume: 9 start-page: 9 year: 2013 article-title: New ACR guidelines for gout management hold some surprises publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2012.216 – volume: 55 start-page: 892 year: 2016 article-title: 2016 Chinese guideline on the diagnosis and management of gout publication-title: Chin J Intern Med – volume: 64 start-page: 1447 year: 2012 article-title: 2012 American College of rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis publication-title: Arthritis Care Res doi: 10.1002/acr.21773 – volume: 11 start-page: 649 year: 2015 article-title: Global epidemiology of gout: prevalence, incidence and risk factors publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2015.91 – year: 2018 article-title: Assessing the quality of global clinical practice guidelines on gout using agree II instrument publication-title: J Clin Rheumatol doi: 10.1097/RHU.0000000000000921 – volume: 74 start-page: 1789 year: 2015 article-title: 2015 gout classification criteria: an American College of Rheumatology/European League against rheumatism collaborative initiative publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2015-208237 – volume: 69 start-page: 1134 year: 2017 article-title: “Official view” on glucocorticoids in rheumatoid arthritis: a systematic review of international guidelines and consensus statements publication-title: Arthritis Care Res doi: 10.1002/acr.23185 – volume: 13 start-page: 561 year: 2017 article-title: Discordant American College of physicians and international rheumatology guidelines for gout management: consensus statement of the gout, hyperuricemia and Crystal-Associated disease network (G-CAN) publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2017.126 – volume: 31 start-page: 370 year: 2016 article-title: An appraisal of clinical practice guidelines for diabetic retinopathy publication-title: Am J Med Qual doi: 10.1177/1062860615574863 – volume: 2015 start-page: 1 issue: 15, supplement year: 2015 article-title: Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis publication-title: Biomed Res Int doi: 10.1155/2015/762820 – volume: 65 start-page: 1312 year: 2006 article-title: EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR standing Committee for international clinical studies including therapeutics (ESCISIT) publication-title: Ann Rheum Dis doi: 10.1136/ard.2006.055269 – volume: 73 start-page: 328 year: 2014 article-title: Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3E initiative publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2013-203325 – volume: 67 start-page: 991 year: 2017 article-title: Evaluation of the current guidelines for resection of hepatocellular carcinoma using the appraisal of guidelines for research and evaluation II instrument publication-title: J Hepatol doi: 10.1016/j.jhep.2017.06.028 – volume: 56 start-page: 1729 year: 2017 article-title: Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for gout publication-title: Rheumatology doi: 10.1093/rheumatology/kex253 – volume: 130 start-page: 2473 year: 2017 article-title: Chinese multidisciplinary expert consensus on the diagnosis and treatment of hyperuricemia and related diseases publication-title: Chin Med J doi: 10.4103/0366-6999.216416 – volume: 56 start-page: 235 year: 2017 article-title: [Chinese multi-disciplinary consensus on the diagnosis and treatment of hyperuricemia and its related diseases] publication-title: Zhonghua Nei Ke Za Zhi doi: 10.3760/cma.j.issn.0578-1426.2017.03.021 – volume: 10 start-page: 241 year: 2012 article-title: The diagnosis and treatment advice of cardiovascular disease combined asymptomatic hyperuricemia (second edition) publication-title: Chin J Cardiovas Res – volume: 11 year: 2013 article-title: Systematic review of clinical practice guidelines in the diagnosis and management of thyroid nodules and cancer publication-title: BMC Med doi: 10.1186/1741-7015-11-191 – volume: 357 year: 2017 article-title: Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies publication-title: BMJ doi: 10.1136/bmj.j2376 – volume: 39 start-page: 158 year: 2014 article-title: Portuguese recommendations for the diagnosis and management of gout publication-title: Acta Reumatol Port – volume: 156 start-page: 367 year: 2012 article-title: What comparative effectiveness research is needed? A framework for using guidelines and systematic reviews to identify evidence gaps and research priorities publication-title: Ann Intern Med doi: 10.7326/0003-4819-156-5-201203060-00009 – volume: 9 year: 2014 article-title: A systematic critical appraisal of non-pharmacological management of rheumatoid arthritis with appraisal of guidelines for research and evaluation II publication-title: PLoS One doi: 10.1371/journal.pone.0095369 – volume: 166 start-page: 52 year: 2017 article-title: Diagnosis of acute gout: a clinical practice guideline from the American College of physicians publication-title: Ann Intern Med doi: 10.7326/M16-0569 – volume: 102 start-page: 61 year: 2004 article-title: A review of the treatment guidelines on the management of low levels of high-density lipoprotein cholesterol publication-title: Cardiology doi: 10.1159/000077906 – volume: 30 start-page: 1018 year: 2011 article-title: Japanese guideline for the management of hyperuricemia and gout: second edition publication-title: Nucleosides, Nucleotides and Nucleic Acids doi: 10.1080/15257770.2011.596496 – volume: 182 start-page: 1045 year: 2010 article-title: Development of the agree II, part 1: performance, usefulness and areas for improvement publication-title: Can Med Assoc J doi: 10.1503/cmaj.091714 – volume: 73 start-page: 1470 year: 2014 article-title: The global burden of gout: estimates from the global burden of disease 2010 study publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2013-204647 – volume: 166 start-page: 73 year: 2017 article-title: The long and winding road to clinical guidelines on the diagnosis and management of gout publication-title: Ann Intern Med doi: 10.7326/M16-2426 – volume: 7 year: 2017 article-title: Diagnosis and treatment for hyperuricaemia and gout: a protocol for a systematic review of clinical practice guidelines and consensus statements publication-title: BMJ Open doi: 10.1136/bmjopen-2016-014928 – volume: 52 start-page: 65 year: 2006 article-title: Conflict between guideline methodologic quality and recommendation validity: a potential problem for practitioners publication-title: Clin Chem doi: 10.1373/clinchem.2005.056952 – volume: 27 start-page: 139 year: 2015 article-title: Evolution of management of gout: a comparison of recent guidelines publication-title: Curr Opin Rheumatol doi: 10.1097/BOR.0000000000000154 – volume: 69 start-page: 594 year: 2002 article-title: Asymptomatic hyperuricemia: to treat or not to treat publication-title: Cleve Clin J Med doi: 10.3949/ccjm.69.8.594 – volume: 318 start-page: 593 year: 1999 article-title: Developing guidelines publication-title: BMJ – ident: 2024052011302869000_9.8.e026677.43 doi: 10.1111/1756-185X.12557 – ident: 2024052011302869000_9.8.e026677.11 doi: 10.1002/art.23007 – ident: 2024052011302869000_9.8.e026677.15 doi: 10.1002/acr.21773 – ident: 2024052011302869000_9.8.e026677.50 – ident: 2024052011302869000_9.8.e026677.58 doi: 10.1136/ard.2006.055269 – volume: 166 start-page: 73 year: 2017 ident: 2024052011302869000_9.8.e026677.23 article-title: The long and winding road to clinical guidelines on the diagnosis and management of gout publication-title: Ann Intern Med doi: 10.7326/M16-2426 – ident: 2024052011302869000_9.8.e026677.20 doi: 10.7326/M16-0570 – volume: 46 start-page: 594 year: 2017 ident: 2024052011302869000_9.8.e026677.68 article-title: The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States publication-title: Semin Arthritis Rheum doi: 10.1016/j.semarthrit.2016.10.009 – volume: 56 start-page: 1729 year: 2017 ident: 2024052011302869000_9.8.e026677.69 article-title: Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for gout publication-title: Rheumatology doi: 10.1093/rheumatology/kex253 – volume: 10 start-page: 241 year: 2012 ident: 2024052011302869000_9.8.e026677.47 article-title: The diagnosis and treatment advice of cardiovascular disease combined asymptomatic hyperuricemia (second edition) publication-title: Chin J Cardiovas Res – volume: 16 year: 2016 ident: 2024052011302869000_9.8.e026677.30 article-title: Clinical practice guidelines for the management of neuropathic pain: a systematic review publication-title: BMC Anesthesiol doi: 10.1186/s12871-015-0150-5 – ident: 2024052011302869000_9.8.e026677.16 doi: 10.1136/annrheumdis-2016-209707 – volume: 67 start-page: 1440 year: 2015 ident: 2024052011302869000_9.8.e026677.64 article-title: Diagnosis, monitoring, and treatment of systemic lupus erythematosus: a systematic review of clinical practice guidelines publication-title: Arthritis Care Res doi: 10.1002/acr.22591 – ident: 2024052011302869000_9.8.e026677.18 doi: 10.1136/ard.2006.055251 – ident: 2024052011302869000_9.8.e026677.53 doi: 10.1136/bmj.318.7183.593 – volume: 29 start-page: 913 year: 2013 ident: 2024052011302869000_9.8.e026677.37 article-title: Chinese consensus on the management of hyperuricemia and gout publication-title: Chin J Endocrinol Metab – ident: 2024052011302869000_9.8.e026677.36 doi: 10.1136/annrheumdis-2013-203325 – ident: 2024052011302869000_9.8.e026677.17 doi: 10.3810/pgm.2011.11.2511 – ident: 2024052011302869000_9.8.e026677.5 doi: 10.1136/annrheumdis-2013-204647 – ident: 2024052011302869000_9.8.e026677.70 doi: 10.7326/0003-4819-156-5-201203060-00009 – volume: 166 start-page: 52 year: 2017 ident: 2024052011302869000_9.8.e026677.19 article-title: Diagnosis of acute gout: a clinical practice guideline from the American College of physicians publication-title: Ann Intern Med doi: 10.7326/M16-0569 – ident: 2024052011302869000_9.8.e026677.26 doi: 10.1097/BOR.0000000000000154 – ident: 2024052011302869000_9.8.e026677.34 – ident: 2024052011302869000_9.8.e026677.66 doi: 10.1159/000077906 – volume: 106 start-page: 549 year: 2009 ident: 2024052011302869000_9.8.e026677.8 article-title: Gout--current diagnosis and treatment publication-title: Dtsch Arztebl Int – volume: 8 year: 2013 ident: 2024052011302869000_9.8.e026677.59 article-title: Quality of clinical practice guidelines for glycemic control in type 2 diabetes mellitus publication-title: PLoS One doi: 10.1371/journal.pone.0058625 – ident: 2024052011302869000_9.8.e026677.1 doi: 10.1002/art.23176 – volume: 55 start-page: 892 year: 2016 ident: 2024052011302869000_9.8.e026677.41 article-title: 2016 Chinese guideline on the diagnosis and management of gout publication-title: Chin J Intern Med – volume: 160 start-page: 38-47 year: 2014 ident: 2024052011302869000_9.8.e026677.29 article-title: Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain publication-title: Ann Intern Med doi: 10.7326/0003-4819-160-1-201401070-00732 – volume: 11 year: 2013 ident: 2024052011302869000_9.8.e026677.31 article-title: Systematic review of clinical practice guidelines in the diagnosis and management of thyroid nodules and cancer publication-title: BMC Med doi: 10.1186/1741-7015-11-191 – ident: 2024052011302869000_9.8.e026677.72 doi: 10.1373/clinchem.2005.056952 – ident: 2024052011302869000_9.8.e026677.44 – volume: 130 start-page: 2473 year: 2017 ident: 2024052011302869000_9.8.e026677.54 article-title: Chinese multidisciplinary expert consensus on the diagnosis and treatment of hyperuricemia and related diseases publication-title: Chin Med J doi: 10.4103/0366-6999.216416 – volume: 69 start-page: 1134 year: 2017 ident: 2024052011302869000_9.8.e026677.63 article-title: “Official view” on glucocorticoids in rheumatoid arthritis: a systematic review of international guidelines and consensus statements publication-title: Arthritis Care Res doi: 10.1002/acr.23185 – ident: 2024052011302869000_9.8.e026677.28 doi: 10.1503/cmaj.090449 – volume: 93 start-page: 961 year: 2003 ident: 2024052011302869000_9.8.e026677.51 article-title: Hyperuricaemia and gout: clinical guideline 2003 publication-title: S Afr Med J – ident: 2024052011302869000_9.8.e026677.52 – volume: 21 start-page: 772 year: 2018 ident: 2024052011302869000_9.8.e026677.55 article-title: Management of gout and hyperuricemia: multidisciplinary consensus in Taiwan publication-title: Int J Rheum Dis doi: 10.1111/1756-185X.13266 – volume: 56 start-page: 1056 year: 2017 ident: 2024052011302869000_9.8.e026677.21 article-title: The British Society for rheumatology guideline for the management of gout publication-title: Rheumatology doi: 10.1093/rheumatology/kex150 – volume: 9 year: 2014 ident: 2024052011302869000_9.8.e026677.71 article-title: A systematic critical appraisal of non-pharmacological management of rheumatoid arthritis with appraisal of guidelines for research and evaluation II publication-title: PLoS One doi: 10.1371/journal.pone.0095369 – volume: 9 start-page: 9 year: 2013 ident: 2024052011302869000_9.8.e026677.24 article-title: New ACR guidelines for gout management hold some surprises publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2012.216 – ident: 2024052011302869000_9.8.e026677.39 doi: 10.1136/annrheumdis-2016-209467 – ident: 2024052011302869000_9.8.e026677.2 doi: 10.1155/2015/690690 – ident: 2024052011302869000_9.8.e026677.56 doi: 10.1097/BOR.0000000000000034 – ident: 2024052011302869000_9.8.e026677.42 doi: 10.1136/annrheumdis-2015-208237 – ident: 2024052011302869000_9.8.e026677.57 doi: 10.1097/RHU.0000000000000921 – volume: 12 year: 2014 ident: 2024052011302869000_9.8.e026677.33 article-title: Diagnosis and treatment of hyponatremia: a systematic review of clinical practice guidelines and consensus statements publication-title: BMC Med doi: 10.1186/s12916-014-0231-1 – ident: 2024052011302869000_9.8.e026677.6 doi: 10.1136/annrheumdis-2013-204463 – volume: 67 start-page: 991 year: 2017 ident: 2024052011302869000_9.8.e026677.67 article-title: Evaluation of the current guidelines for resection of hepatocellular carcinoma using the appraisal of guidelines for research and evaluation II instrument publication-title: J Hepatol doi: 10.1016/j.jhep.2017.06.028 – ident: 2024052011302869000_9.8.e026677.65 doi: 10.1136/qshc.2010.042077 – ident: 2024052011302869000_9.8.e026677.35 doi: 10.1503/cmaj.091714 – volume: 39 start-page: 158 year: 2014 ident: 2024052011302869000_9.8.e026677.40 article-title: Portuguese recommendations for the diagnosis and management of gout publication-title: Acta Reumatol Port – ident: 2024052011302869000_9.8.e026677.12 doi: 10.1002/art.22767 – volume: 357 year: 2017 ident: 2024052011302869000_9.8.e026677.7 article-title: Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies publication-title: BMJ doi: 10.1136/bmj.j2376 – volume: 7 year: 2017 ident: 2024052011302869000_9.8.e026677.27 article-title: Diagnosis and treatment for hyperuricaemia and gout: a protocol for a systematic review of clinical practice guidelines and consensus statements publication-title: BMJ Open doi: 10.1136/bmjopen-2016-014928 – volume: 67 start-page: 2690 year: 2015 ident: 2024052011302869000_9.8.e026677.4 article-title: March L: Global prevalence of hyperuricemia: a systematic review of population-based epidemiological studies publication-title: Arthritis & Rheumatology – volume: 65 start-page: 4 year: 2013 ident: 2024052011302869000_9.8.e026677.45 article-title: Italian Society of rheumatology recommendations for the management of gout publication-title: Reumatismo – ident: 2024052011302869000_9.8.e026677.49 – volume: 13 start-page: 561 year: 2017 ident: 2024052011302869000_9.8.e026677.25 article-title: Discordant American College of physicians and international rheumatology guidelines for gout management: consensus statement of the gout, hyperuricemia and Crystal-Associated disease network (G-CAN) publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2017.126 – volume: 59 start-page: 1799 year: 1999 ident: 2024052011302869000_9.8.e026677.10 article-title: Diagnosis and management of gout publication-title: Am Fam Physician – ident: 2024052011302869000_9.8.e026677.32 doi: 10.1002/art.24207 – ident: 2024052011302869000_9.8.e026677.62 doi: 10.1016/j.jclinepi.2014.07.005 – volume: 30 start-page: 1 year: 2016 ident: 2024052011302869000_9.8.e026677.38 article-title: Taiwan guideline for the management of gout and hyperuricemia - updated 2016 publication-title: F J Rheumatol – ident: 2024052011302869000_9.8.e026677.60 doi: 10.1177/1062860615574863 – ident: 2024052011302869000_9.8.e026677.9 doi: 10.3949/ccjm.69.8.594 – volume: 56 start-page: 235 year: 2017 ident: 2024052011302869000_9.8.e026677.22 article-title: [Chinese multi-disciplinary consensus on the diagnosis and treatment of hyperuricemia and its related diseases] publication-title: Zhonghua Nei Ke Za Zhi – ident: 2024052011302869000_9.8.e026677.3 doi: 10.1038/nrrheum.2015.91 – ident: 2024052011302869000_9.8.e026677.46 – ident: 2024052011302869000_9.8.e026677.48 doi: 10.1080/15257770.2011.596496 – volume: 360 year: 2018 ident: 2024052011302869000_9.8.e026677.13 article-title: Clinical practice guidelines in China publication-title: BMJ doi: 10.1136/bmj.j5158 – ident: 2024052011302869000_9.8.e026677.14 doi: 10.1002/acr.21772 – volume: 60 start-page: 4 year: 2018 ident: 2024052011302869000_9.8.e026677.61 article-title: Appraisal of clinical practice guidelines on the management of hypothyroidism in pregnancy using the appraisal of guidelines for research and evaluation II instrument publication-title: Endocrine doi: 10.1007/s12020-018-1535-2 |
| SSID | ssj0000459552 |
| Score | 2.5549598 |
| SecondaryResourceType | review_article |
| Snippet | ObjectivesDespite the publication of hundreds of trials on gout and hyperuricemia, management of these conditions remains suboptimal. We aimed to assess the... Despite the publication of hundreds of trials on gout and hyperuricemia, management of these conditions remains suboptimal. We aimed to assess the quality and... Objectives Despite the publication of hundreds of trials on gout and hyperuricemia, management of these conditions remains suboptimal. We aimed to assess the... |
| SourceID | doaj pubmedcentral proquest pubmed crossref bmj |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e026677 |
| SubjectTerms | Cardiology Clinical medicine clinical practice guideline Clinical practice guidelines Consensus Diabetes and Endocrinology Diabetic retinopathy Evidence-based medicine gout Gout - blood Gout - diagnosis Gout - therapy Gout Suppressants - pharmacology Humans hyperuricemia Hyperuricemia - drug therapy Hyperuricemia - therapy Medical diagnosis Patients Practice Guidelines as Topic - standards Quality Rheumatism Rheumatoid arthritis Rheumatology Systematic review Task forces Uric Acid - analysis |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4k2gICMhwYGoiZ8xN15VhVROVOot8rNdRLOou7nz05mxs-kuQoUDlxxiW3FmxvY38sw3hLzsUlBRBls747taAMKvARWZWnqN5C4AGRpMcD7-oo5OxOdTebpV6gtjwgo9cBHcQVA6hQQ-HA9StCZ1jXQCUHFsrZCW5923Mc2WM5X3YCGNlGyiGWq5OnAX37AeFVhF29XgeCiNBxK83TmQMm__n8Dm7zGTW4fQ4R1ye0KP9F2Z9V1yIw73yM3j6X78Pvn5sUTOLVbUDoHOUeQUoCk9B5fzMpMIXSxsbj9bjuu31NIrOmdaUlnoMtFNziTdJFLRsxE5sTBOPo_2GIg9rMYVzVlJOVfuATk5_PT1w1E91VioHSChdR105J4lzaxiTiUr24i1N7gzJnETvZbSN6HtEhx0gDakj96GlHSjPSAh6_hDsjcsh_iY0I45F0WyARa5sMx3CvQT4CE08zKEirwGcffTGln12f3gqp8006Nm-qKZirzCrj8K4cb1PdlGe72fWM2xuMb36we9mQf90zfeo1nMXZGRO78AO-0nO-3_ZqcV2d8Y1ZUIGIM9nknGeUVezM2wwPHWxg5xOeY-SMoGMq3Io2KD80w4evOigdF6xzp3prrbMizOM4m4wupESj35H__2lNwCcZkSF7lP9taXY3wGWG3tnudl-QsYrDzE priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELagSIgL4k1KQUZCggNREye2Ey6IV1UhlROV9hb5uV1Ek3azufPTmXGcLIvQisseYjtrjWfib-yZbwh5VXkrHLcq1bWp0hIQfgqoqE65kUjuApAhwwTns2_i9Lz8uuCLeODWx7DK6ZsYPtS2M3hGfswYmAMDt6l4f3WdYtUovF2NJTRuklvhtaDPciHnMxaAKzXnLJIN5YU41pc_sCoV6EZepeB-CInbEjzd2ZYCe_-_IOffkZN_bEUn98jdiCHph3HR75Mbrn1Abp_FW_KH5NfnMX5u1VPVWjrHklMAqPQCHM91oBK6XKnQvuyGzTuq6JbUmY4JLbTzdMqcpFM6FV0OyIyF0fJhtMFw7LYfehpyk0LG3CNyfvLl-6fTNFZaSDXgoU1qpSsM85IpwbTwiucOK3AUuq59UTsjOTeZzSsP2x1gDm6cUdZ7mUkDeEjp4jE5aLvWPSW0Ylq70isLpl4qZirBVWHhp5TMcGsT8gbE3URL6ZvghBSiiSvT4Mo048ok5DV2vRppN_b3ZNPqNSZym2OJjZ_7B72dB_3Xf3xEtZi7Ii93eNCtl00088YK6a0XdVZYXua1rzKuS_DhXK5KkANLyNGkVFsRbFU7IS_nZjBzvLtRreuG0Aep2UCmCXky6uA8kwJ9-jKD0XJHO3emutvSri4ClbjAGkVCHO6f1jNyBwRRj3GPR-Rgsx7cc8BiG_0iGNxvDiA05A priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9RAEF_aCqUv4rfRKisI-mA02c9EEPGrFKE-edC3sJ_XkzbRuwvom3-6s5tN6kktfTnI7WwSZia7v2FnfoPQ08pb4bhVua5NlTNA-DmgojrnRgZyF4AMRShwPvoiDmfs8zE_3kJjV9SkwNWFoV3oJzVbnr78-ePXW_jg36SOJK_02bcwBAYvqxxiCiHlNroWD4xCLl_C-3FpZrzmsQsPKRjLAcrzxET0n_vsoV0aIiYWmmptg8DG9hVZ_i-Cpv9mWP61ZR3cQNcT1sTvBue4ibZcewvtHqXT9Nvo98chz26xwqq1eMo5xwBk8QkEqMtIOXS2UHF83vXr11jhc_JnPBS-4M7jscISj2VXeN4HBq2QVR9nm5C23a76FY41TLGy7g6aHXz6-uEwTx0Zcg24aZ1b6aghXhIliBZe8dKFTh1U17WntTOSc1PYsvKwLQI24cYZZb2XhTSAm5Smd9FO27XuPsIV0doxrywsCUwRUwmuqIUfJonh1mboOai7GR2iicEKFU0yUhOM1AxGytCzIPp9oOe4XJKM1mtM4kAPrThOL5_0Ypp0pWe8D24xiQb-7vhHt5w3aTlorJDeelEX1HJW1r4quGYQ67lSMdADydD-6FTnKiAEdgTCCaUZejINw3IQznhU67o-ygQKN9Bphu4NPji9yejJGZIb3rnxqpsj7eIkUo6L0MtIiAdXN8pDtAdX9ZAruY921svePQL8ttaP4zf5B2nCQGQ priority: 102 providerName: Scholars Portal |
| Title | Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements |
| URI | https://bmjopen.bmj.com/content/9/8/e026677.full https://www.ncbi.nlm.nih.gov/pubmed/31446403 https://www.proquest.com/docview/2288725233 https://www.proquest.com/docview/2280555174 https://pubmed.ncbi.nlm.nih.gov/PMC6720466 https://doaj.org/article/d67fdf6903d5419f805b4118e1a45a32 |
| Volume | 9 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dT9RAEN8IJMYXg59U8bImJvpgY7ufLW-AIDEpMQbM-dTsJ5yRnuGu7_zpzG57hRolvOzluru9Zmb29jfdmd8g9K7wVjhuVapLU6QMEH4KqKhMuZGB3AUgQxYSnKtjcXTKvk759Fay-vgEP6fik774FQpJgTrzIgWPQUi5hjaIBE8hGPTPk-GVCqCTkscaOyRjLAWgznueof_cB_YTuDrakSJx_7_Q5t9Bk7d2ocNN9LiHj3i30_cT9MA1T9HDqj8gf4auPnehc7MFVo3FQxg5BmyKz8HnvIwsQhczFfvP5u1yByt8w-eMu1wWPPd4lTSJV5lU-KwNpFghUD7ONiESu1m0CxzTkmKy3HN0enhwsn-U9kUWUg1QaJla6aghXhIliBZe8dyF4htUl6WnpTOSc5PZvPCw0wHc4MYZZb2XmTQAhZSmL9B6M2_cFsIF0doxryyscqaIKQRX1ELDJDHc2gR9AHHX_SJZ1NH_oKLuNVMHzdSdZhL0Pgz90zFu3D2SrLRXm57WPFTX-H33pI_DpHv9xl4wi2FooOSOF8BO636F11ZIb70oM2o5y0tfZFwzcN9crhjIgSRoe2VUNyIgBP7kCSeUJujt0A0rPBzbqMbN2zgmsLKBTBP0srPB4UlocOdZBrPlyDpHjzruaWbnkUVchPJEQry6t6Rfo0fwreyiH7fR-vKydW8AkS31BK3JqZzE1ThBG7v7VfUDPvcOjr99n8S3HNB-mebQVqy4BjDmN5g |
| linkProvider | BMJ Publishing Group Ltd |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3JbtQw1CpFAi6InUABI4HgQNTEie0ECSGgVFPa6amV5hYcL9Op2qTMIsSNL-Ibec9ZhkFoxKWXOXjJWG9_9lsIeZE5Iyw3KixznYUpWPghWEV5yLXE4i5gMkSY4Dw8FIPj9MuIjzbIry4XBsMqO5noBbWpNd6RbzMG7MDAbUreX3wLsWsUvq52LTQasti3P76DyzZ7t7cD-H3J2O7no0-DsO0qEJag--ehkTbRzEmmBCuFUzy22G0iKfPcJbnVknMdmThzINpBv3JttTLOyUhq0P2qTOC7V8jVFJ8YgX_kSPZ3OjCSc87a4kZxIrbL81PsggW0GGchuDtCohqE0RU16LsF_MvE_TtS8w_Vt3uL3GxtVvqhIbLbZMNWd8i1Yfsqf5f83Gni9SYzqipD-9h1CgYxPQFHd-pLF51PlJ8f14v5W6rosog0bRJoaO1ol6lJu_QtOl5gJS6Mzve7NYZ_V7PFjPpcKJ-hd48cXwoO7pPNqq7sQ0IzVpY2dcqAaEkV05ngKjHwk0qmuTEBeQ3gLlrOnBXe6UlE0WKmQMwUDWYC8gqXXjRlPtavZB32Ct3WUseWHmfrN73pN_3Xf3xEsuiXYh1wP1BPx0UrVgojpDNO5FFieBrnLot4mYLPaGOVAhxYQLY6olqCYMlKAXneT4NYwbciVdl64ddgKTiAaUAeNDTYnyTBO4Q0gt1yhTpXjro6U01OfOlygT2RhHi0_ljPyPXB0fCgONg73H9MbgBQ8ibmcotszqcL-wTswHn51DMfJV8vm9t_Ay8fcl8 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkSouiDeBAkYCwYFoEz8TJISAZdVSWnGg0t5Sx4_tIpqUfQhx43fx6xg7j2URWnHpJYfYTizPwzP2zDcIPcmcEZYbFZe5zmIGFn4MVlEecy09uAuYDIlPcD48EnvH7MOYj7fQry4XxodVdjoxKGpTa39GPiAExIGA20QHrg2L-DQcvT7_FvsKUv6mtSun0bDIgf3xHdy3-av9IdD6KSGj95_f7cVthYG4BDtgERtpqSZOEiVIKZziqfWVJ2iZ547mVkvOdWLSzIGah72Wa6uVcU4mUoMdoEoK372ELkvKmC8bIceyP98BUynnnLRARykVg_Lsi6-IBXyZZjG4PkL6LRHerm2JoXLAv8zdv6M2_9gGR9fQ1dZ-xW8ahruOtmx1A-0ctjf0N9HPYRO7N51jVRncx7FjMI7xKTi9swBjdDZVoX1SLxcvscIrQGncJNPg2uEuaxN3qVx4svSoXD5SP4zWPhS8mi_nOORFhWy9W-j4QmhwG21XdWXvIpyRsrTMKQNqhimiM8EVNfBgkmhuTISew3IXrZTOi-AAUVG0lCk8ZYqGMhF65rueN5Afm3uSjnqFbnHVfXmPr5sHvegH_dc_3nq26Lt6TPDwop5NilbFFEZIZ5zIE2o4S3OXJbxk4D_aVDFYBxKh3Y6pVkuwEqsIPe6bQcX4eyNV2XoZ-nhYOFjTCN1peLCfCfXnCSyB0XKNO9emut5STU8DjLnw9ZGEuLd5Wo_QDsh58XH_6OA-ugJrkjfhl7toezFb2gdgEi7Kh0H2MDq5aGH_DVK-dpI |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diagnosis+and+treatment+for+hyperuricemia+and+gout%3A+a+systematic+review+of+clinical+practice+guidelines+and+consensus+statements&rft.jtitle=BMJ+open&rft.au=Li%2C+Qianrui&rft.au=Li%2C+Xiaodan&rft.au=Wang%2C+Jing&rft.au=Liu%2C+Hongdie&rft.date=2019-08-01&rft.pub=British+Medical+Journal+Publishing+Group&rft.issn=2044-6055&rft.eissn=2044-6055&rft.volume=9&rft.issue=8&rft_id=info:doi/10.1136%2Fbmjopen-2018-026677&rft_id=info%3Apmid%2F31446403&rft.externalDBID=bmjopen&rft.externalDocID=bmjopen |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2044-6055&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2044-6055&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2044-6055&client=summon |